Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | FPR2 | P25090 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.32 |
| ▸ | RELA | Q04206 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22129305 | 1.00 | ADRB2 (0.33) | ADRB2ALDH1A1MAPTL3MBTL1HTT | |
| SCHEMBL22129298 | 1.00 | ADRB2 (0.33) | ADRB2ALDH1A1MAPTL3MBTL1HTT | |
| SCHEMBL23749531 | 0.86 | FPR2 (0.35) | ADRB2ALDH1A1MAPTL3MBTL1HTT | |
| SCHEMBL28499370 | 0.86 | FPR2 (0.35) | ADRB2ALDH1A1MAPTL3MBTL1HTT | |
| SCHEMBL23749533 | 0.86 | FPR2 (0.35) | ADRB2ALDH1A1MAPTL3MBTL1HTT | |
| SCHEMBL22129296 | 0.82 | HCAR3 (0.38) | ALDH1A1MAPTL3MBTL1HTTRAB9A | |
| SCHEMBL29743229 | 0.82 | HCAR3 (0.38) | ALDH1A1MAPTL3MBTL1HTTRAB9A | |
| SCHEMBL22129297 | 0.82 | HCAR3 (0.38) | ALDH1A1MAPTL3MBTL1HTTRAB9A | |
| SCHEMBL29743215 | 0.82 | HCAR3 (0.38) | ALDH1A1MAPTL3MBTL1HTTRAB9A | |
| SCHEMBL22010774 | 0.77 | KMT2A (0.37) | ALDH1A1HTTKDM4EHSD17B10NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111989332-B | Macrocyclic compounds as CDK inhibitors, their preparation and their use in medicine | 凯复(苏州)生物医药有限公司 | 2022-07-26 | — | — | CN | disclosed |
| US-20220017520-A1 | MACROCYCLIC COMPOUND AS CDK INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF IN MEDICINE | Keythera (Suzhou) Pharmaceuticals Co. Ltd. (CN) | 2022-01-20 | — | — | US | disclosed |
| EP-3865488-A1 | MACROCYCLIC COMPOUND AS CDK INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF IN MEDICINE | Keythera (Suzhou) Pharmaceuticals Co. Ltd. (CN) | 2021-08-18 | — | — | EP | disclosed |
| EP-3865488-A1 | MACROCYCLIC COMPOUND AS CDK INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF IN MEDICINE | Keythera (Suzhou) Pharmaceuticals Co. Ltd. (CN) | 2021-08-18 | — | — | EP | disclosed |
| CN-111989332-A | Macrocyclic compounds as CDK inhibitors, method for the production thereof and their use in medicine | 凯复(苏州)生物医药有限公司 | 2020-11-24 | — | — | CN | disclosed |
| WO-2020125513-A1 | MACROCYCLIC COMPOUND AS CDK INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF IN MEDICINE | 凯复制药有限公司 | 2020-06-25 | — | — | WO | disclosed |
| WO-2020125513-A1 | MACROCYCLIC COMPOUND AS CDK INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF IN MEDICINE | 凯复制药有限公司 | 2020-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220017520-A1 | MACROCYCLIC COMPOUND AS CDK INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF IN MEDICINE | CDK4, CDK7, CDKL1 | ADRB2 4562/4885ALDH1A1 4060/4885MAPT 3275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.